Key Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Key Financial's AXSM Position: Q3 2026 in Review
Key Financial held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 450 shares worth $83K. The position accounts for 0.01% of the portfolio, ranked #457.
Key Financial first reported a position in AXSM in Q3 2021 and has held it in 21 quarters since. The position peaked at $110K in Q2 2026. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Key Financial held 450 shares of Axsome Therapeutics worth $83K as of Q3 2026.
- Key Financial left its Axsome Therapeutics share count unchanged in Q3 2026.
- Axsome Therapeutics made up 0.01% of Key Financial's portfolio in Q3 2026, its #457 holding.
- Key Financial first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 21 quarters since.
- Key Financial's Axsome Therapeutics position peaked at $110K in Q2 2026.
- 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.